A unit of Unilab, Inc. has expanded its manufacturing operations to Sta. Rosa, Laguna, the Board of Investments (BoI) said in a statement Tuesday.
The BoI said Amherst Parenterals, Inc. inaugurated a new sterile liquid production line on April 29, which involves an investment of 291.21 million pesos.
“Amherst’s new production line will be used in the manufacture of sterile liquid solutions for nebulization (respiratory therapeutics) as part of the company’s commitment to providing Filipinos with easy access to quality healthcare products. quality and affordable,” the BoI said.
According to the BoI, Amherst was registered on September 23 and manufactures nebulous respiratory therapy products such as Salbutamol and Salbutamol + Ipratropium.
BoI Chief Executive Bobby G. Fondevilla said: “The government greatly appreciates the company’s efforts and commitment to providing our people with easy access to quality and affordable healthcare…this decision trade is very important as the country continues to recover from the coronavirus. pandemic disease 2019 (COVID-19).
Recent BoI health industry approvals include a 24 million peso project by Lloyd Laboratories, Inc., which seeks to become a local producer of the oral COVID-19 drug Molnupiravir; and Medtecs International Corp’s $1.9 billion project. ltd. aimed at establishing an industrial complex focused on the production of personal protective equipment (PPE), as well as electric vehicles (EVs) and textiles.
The BoI said the Lloyd Laboratories project will have an annual production capacity of one million 400 milligram (mg) capsules of Molnupiravir while the Medtecs project will generate 125,000 jobs over seven years. — Revin Mikhael D. Ochave